Search research articles
Contact Us
Filters
Showing results (41-50 of 96) with videos related to
Page
of 10
Sort By:
The Prostate
|
August 8, 2020
Predicting new drug indications for prostate cancer: The integration of an in silico proteochemometric network pharmacology platform with patient-derived primary prostate cells
Aisha Naeem, Sivanesan Dakshanamurthy, Henry Walthieu, et al.
Cancer Research
|
December 20, 2011
Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer
Hong Yang, Brian Higgins, Kenneth Kolinsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2016
Branched Chain RNA In Situ Hybridization for Androgen Receptor Splice Variant AR-V7 as a Prognostic Biomarker for Metastatic Castration-Sensitive Prostate Cancer
Philip J Saylor, Richard J Lee, Kshitij S Arora, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 15, 2024
The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancer
Philip J Saylor, Sergey V Kozin, Aya Matsui, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2012
Marked, homogeneous, and early [18F]fluorodeoxyglucose-positron emission tomography responses to vemurafenib in BRAF-mutant advanced melanoma
Grant A McArthur, Igor Puzanov, Ravi Amaravadi, et al.
The New England Journal of Medicine
|
September 8, 2010
Inhibition of mutated, activated BRAF in metastatic melanoma
Keith T Flaherty, Igor Puzanov, Kevin B Kim, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 17, 2023
Clinical Outcomes of De Novo Versus Relapsed Early Metastatic Testicular Seminoma Treated With Contemporary Radiation Therapy
Daniel B Rosen, Anushka Ghosh, Andrzej Niemierko, et al.
Urologic Oncology
|
October 11, 2025
PSA density as a dynamic prognostic marker of biopsy grade progression during active surveillance
Andrew Gusev, Florian Rumpf, Dimitar Zlatev, et al.
Eclinicalmedicine
|
November 29, 2021
A method for the identification of COVID-19 biomarkers in human breath using Proton Transfer Reaction Time-of-Flight Mass Spectrometry
Aikaterini Liangou, Antonios Tasoglou, Heinz J Huber, et al.
Practical Radiation Oncology
|
March 29, 2014
Anatomic differences after robotic-assisted radical prostatectomy and open prostatectomy: implications for radiation field design
Ariel E Hirsch, John J Cuaron, Milos J Janicek, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 96) with videos related to
Sort By:
Page
of 10
The Prostate
|
August 8, 2020
Predicting new drug indications for prostate cancer: The integration of an in silico proteochemometric network pharmacology platform with patient-derived primary prostate cells
Aisha Naeem, Sivanesan Dakshanamurthy, Henry Walthieu, et al.
Cancer Research
|
December 20, 2011
Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer
Hong Yang, Brian Higgins, Kenneth Kolinsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2016
Branched Chain RNA In Situ Hybridization for Androgen Receptor Splice Variant AR-V7 as a Prognostic Biomarker for Metastatic Castration-Sensitive Prostate Cancer
Philip J Saylor, Richard J Lee, Kshitij S Arora, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 15, 2024
The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancer
Philip J Saylor, Sergey V Kozin, Aya Matsui, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2012
Marked, homogeneous, and early [18F]fluorodeoxyglucose-positron emission tomography responses to vemurafenib in BRAF-mutant advanced melanoma
Grant A McArthur, Igor Puzanov, Ravi Amaravadi, et al.
The New England Journal of Medicine
|
September 8, 2010
Inhibition of mutated, activated BRAF in metastatic melanoma
Keith T Flaherty, Igor Puzanov, Kevin B Kim, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 17, 2023
Clinical Outcomes of De Novo Versus Relapsed Early Metastatic Testicular Seminoma Treated With Contemporary Radiation Therapy
Daniel B Rosen, Anushka Ghosh, Andrzej Niemierko, et al.
Urologic Oncology
|
October 11, 2025
PSA density as a dynamic prognostic marker of biopsy grade progression during active surveillance
Andrew Gusev, Florian Rumpf, Dimitar Zlatev, et al.
Eclinicalmedicine
|
November 29, 2021
A method for the identification of COVID-19 biomarkers in human breath using Proton Transfer Reaction Time-of-Flight Mass Spectrometry
Aikaterini Liangou, Antonios Tasoglou, Heinz J Huber, et al.
Practical Radiation Oncology
|
March 29, 2014
Anatomic differences after robotic-assisted radical prostatectomy and open prostatectomy: implications for radiation field design
Ariel E Hirsch, John J Cuaron, Milos J Janicek, et al.
Page
of 10